{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:58:10Z","timestamp":1777039090344,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012259","name":"Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20213BCJL22049"],"award-info":[{"award-number":["20213BCJL22049"]}],"id":[{"id":"10.13039\/501100012259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901090"],"award-info":[{"award-number":["81901090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271447"],"award-info":[{"award-number":["82271447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012556","name":"Foundation for Innovative Research Groups of Hubei Province of China","doi-asserted-by":"publisher","award":["2022CFA026"],"award-info":[{"award-number":["2022CFA026"]}],"id":[{"id":"10.13039\/501100012556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110685","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:03:50Z","timestamp":1758686630000},"page":"110685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibiting MARS attenuates hyperhomocysteinemia-associated neurodegeneration in Parkinson's disease"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-8686","authenticated-orcid":false,"given":"Tao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2948-979X","authenticated-orcid":false,"given":"Dandan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6708-1472","authenticated-orcid":false,"given":"Zhentao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2025.110685_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"May","key":"10.1016\/j.neuropharm.2025.110685_bib3","article-title":"Chronopharmacological targeting of rev-erb\u03b1 by puerarin alleviates hyperhomocysteinemia in mice","volume":"125","author":"Chen","year":"2020","journal-title":"Biomed. Pharm. = Biomed. Pharmacother."},{"issue":"October","key":"10.1016\/j.neuropharm.2025.110685_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.msard.2017.08.004","article-title":"Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a Meta-analysis","volume":"17","author":"Dardiotis","year":"2017","journal-title":"Multiple Sclerosis Related Disorders"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy Body-like Alpha-synuclein inclusions Trigger reactive Microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110685_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030393","article-title":"Homocysteine induces inflammation in Retina and brain","volume":"10","author":"Elsherbiny","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110685_bib7","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1074\/jbc.M313268200","article-title":"Cross-talk between Cys34 and lysine residues in human serum Albumin revealed by N-homocysteinylation","volume":"279","author":"Glowacki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110685_bib8","first-page":"1","article-title":"N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease","author":"Guo","year":"2024","journal-title":"Aging Cell"},{"issue":"September","key":"10.1016\/j.neuropharm.2025.110685_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pbb.2014.06.020","article-title":"Evaluation of the association between Blood homocysteine concentration and the degree of behavioral Symptoms in the 6-hydroxydopamine-induced parkinsonism in rat","volume":"124","author":"Haghdoost-Yazdi","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0216-4","article-title":"Disturbed homocysteine metabolism is associated with cancer","volume":"51","author":"Hasan","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cmet.2017.10.015","article-title":"Sensing and transmitting intracellular amino acid signals through reversible lysine aminoacylations","volume":"27","author":"He","year":"2018","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1471-4159.2001.00384.x","article-title":"Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress","volume":"78","author":"Ho","year":"2001","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110685_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-003-3204-7","article-title":"Molecular basis of homocysteine toxicity in humans","volume":"61","author":"Jakubowski","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"issue":"15","key":"10.1016\/j.neuropharm.2025.110685_bib15","first-page":"2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"issue":"2S Suppl. l","key":"10.1016\/j.neuropharm.2025.110685_bib16","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1093\/jn\/130.2.377S","article-title":"Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans","volume":"130","author":"Jakubowski","year":"2000","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110685_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(93)81283-6","article-title":"Synthesis of homocysteine thiolactone by methionyl-TRNA synthetase in cultured mammalian cells","volume":"317","author":"Jakubowski","year":"1993","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110685_bib18","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1515\/CCLM.2003.224","article-title":"Homocysteine-thiolactone and S-Nitroso-Homocysteine mediate incorporation of homocysteine into protein in humans","volume":"41","author":"Jakubowski","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.18388\/abp.2011_2259","article-title":"Quality control in TRNA Charging -- editing of homocysteine","volume":"58","author":"Jakubowski","year":"2011","journal-title":"Acta Biochim. Pol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/physrev.00003.2018","article-title":"Homocysteine modification in protein structure\/function and human disease","volume":"99","author":"Jakubowski","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110685_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.trecan.2018.10.006","article-title":"Protein N-homocysteinylation and Colorectal cancer","author":"Jakubowski","year":"2019","journal-title":"Trends Cancer"},{"issue":"24","key":"10.1016\/j.neuropharm.2025.110685_bib22","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1073\/pnas.90.24.11553","article-title":"The relationship between synthetic and editing functions of the active site of an aminoacyl-TRNA synthetase","volume":"90","author":"Kim","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110685_bib23","article-title":"An alternative strategy for pan-acetyl-lysine antibody generation","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110685_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2007.03.008","article-title":"Hyperhomocysteinemia, inflammation and autoimmunity","volume":"6","author":"Lazzerini","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib25","article-title":"Nonlinear association between blood lead and hyperhomocysteinemia among adults in the United States","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"issue":"November","key":"10.1016\/j.neuropharm.2025.110685_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.08.005","article-title":"Homocysteine and cognitive function in Parkinson's disease","volume":"44","author":"Licking","year":"2017","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110685_bib27","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.celrep.2016.08.053","article-title":"Molecular and biological compatibility with Host Alpha-synuclein influences fibril pathogenicity","volume":"16","author":"Luk","year":"2016","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110685_bib28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jnen\/nly040","article-title":"DNA damage response and repair, DNA methylation, and cell death in human neurons and experimental animal neurons are different","volume":"77","author":"Martin","year":"2018","journal-title":"JNEN (J. Neuropathol. Exp. Neurol.)"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-025-00830-3","article-title":"Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's disease","volume":"20","author":"Martiskainen","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110685_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-025-02010-4","article-title":"Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson's disease","author":"Marutani","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.neuropharm.2025.110685_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain : J. Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110685_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","article-title":"Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders","volume":"26","author":"Mattson","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110685_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1179807","article-title":"Homocysteine-a retrospective and prospective appraisal","volume":"10","author":"McCaddon","year":"2023","journal-title":"Front. Nutr."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110685_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809469","article-title":"Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects","volume":"12","author":"Mei","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110685_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084176","article-title":"Neuromelanin in Parkinson's disease: tyrosine hydroxylase and tyrosinase","volume":"23","author":"Nagatsu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110685_bib36","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and Spreading in Parkinson's disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain : J. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110685_bib37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmb.2010.05.039","article-title":"Protein N-homocysteinylation induces the formation of toxic amyloid-like Protofibrils","volume":"400","author":"Paoli","year":"2010","journal-title":"J. Mol. Biol."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110685_bib38","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1021\/bi602463m","article-title":"Modification by homocysteine thiolactone affects redox status of cytochrome C","volume":"46","author":"Per\u0142a-Kaj\u00e1n","year":"2007","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12020399","article-title":"Investigation of paraoxonase-1 Genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson's disease","volume":"12","author":"Petri\u010d","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110685_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","article-title":"Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term","volume":"135","author":"Rey","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110685_bib41","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","article-title":"Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb Mimics Prodromal Parkinson's disease","volume":"213","author":"Rey","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2025.110685_bib42","article-title":"Serum homocysteine level in Parkinson's disease and its association with duration, Cardinal Manifestation, and severity of disease","volume":"2018","author":"Saadat","year":"2018","journal-title":"Parkinsons Dis."},{"issue":"March","key":"10.1016\/j.neuropharm.2025.110685_bib43","article-title":"Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease","volume":"434","author":"Sampedro","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110685_bib44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/joim.13279","article-title":"Homocysteine - from disease Biomarker to disease Prevention","volume":"290","author":"Smith","year":"2021","journal-title":"J. Intern. Med."},{"issue":"44","key":"10.1016\/j.neuropharm.2025.110685_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq3539","article-title":"Mouse \u03b1-synuclein fibrils are structurally and Functionally distinct from human fibrils associated with Lewy Body diseases","volume":"10","author":"Sokratian","year":"2024","journal-title":"Sci. Adv."},{"issue":"36","key":"10.1016\/j.neuropharm.2025.110685_bib46","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","article-title":"The effect of fragmented pathogenic \u03b1-synuclein seeds on Prion-like Propagation","volume":"291","author":"Tarutani","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110685_bib47","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.celrep.2018.09.022","article-title":"Colonic lysine homocysteinylation induced by high-fat diet suppresses DNA damage repair","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110685_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","article-title":"Homocysteine and Cardiovascular disease: a review of the Evidence","volume":"4","author":"Wierzbicki","year":"2007","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110685_bib50","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1039\/C4AN02355B","article-title":"Crosstalk of homocysteinylation, methylation and acetylation on histone H3","volume":"140","author":"Xu","year":"2015","journal-title":"The Analyst"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110685_bib51","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves \u03b1-synuclein and mediates pathologic activities in Parkinson's disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110685_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4797861","article-title":"Elevation of plasma homocysteine and minor hallucinations in Parkinson's disease: a cross-sectional study","volume":"2022","author":"Zhong","year":"2022","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110685_bib53","first-page":"1","article-title":"N-homocysteinylation of \u03b1-synuclein promotes its aggregation and neurotoxicity","author":"Zhou","year":"2022","journal-title":"Aging Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:23:17Z","timestamp":1773127397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0028390825003934"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110685","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting MARS attenuates hyperhomocysteinemia-associated neurodegeneration in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110685"}}